← Leaderboards
Gerald Maxwell Cherf
Stanford University
$145,514
Attributed
$145,514
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $43.1K · FY2014–17$50K$37.5K$25K$12.5K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$145,514 · 1
By mechanism
F31$145,514 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Sylvia Katina Plevritis$44,733,712
- Amato J. Giaccia$32,506,927
- Edgar G. Engleman$35,389,843
- Katherine W Ferrara$45,937,231
- Melanie Hayden Gephart$6,763,817
Others in their field
Top investigators on “Evolution”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric J Barron · Pennsylvania State Univ University Park$246,372,016
- Everette D Joseph · Howard University$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- David W Simpson · University Of Southern California$231,675,195
Research focus
EvolutionAnimal ModelAmino AcidsEpitopesBiological MarkersBiological ProcessBloodBreast Cancer CellAffinityCancer CellCancer TherapyCause Of DeathCell AdhesionCellsCessation Of LifeChemotherapyClinicCollaborationsCommunitiesCoupledDisseminated Malignant NeoplasmEfficacy TestingEngineeringFda Approved
Grant awards (4)
Engineering a multispecific cell receptor antagonist to treat metastatic cancer$24,211
F31 · FY2017 · CA · contact PI
Engineering a multispecific cell receptor antagonist to treat metastatic cancer$35,507
F31 · FY2016 · CA · contact PI
Engineering a multispecific cell receptor antagonist to treat metastatic cancer$43,120
F31 · FY2015 · CA · contact PI
Engineering a multispecific cell receptor antagonist to treat metastatic cancer$42,676
F31 · FY2014 · CA · contact PI